CardioVascular and Interventional Radiology

, Volume 42, Issue 9, pp 1329–1330 | Cite as

Chemoembolization of HCC: Time for Technical Standardization, or Is It Too Late?

  • Olivier PellerinEmail author
  • Tom Boeken
  • Boris Guiu


Compliance with Ethical Standards

Conflict of interest

None of the authors have any conflict of interest or financial disclosures to declare.


  1. 1.
    Basile A, Carrafiello G, Ierardi AM, Tsetis D, Brountzos E. Quality-improvement guidelines for hepatic transarterial chemoembolization. Cardiovasc Interv Radiol. 2012;35(4):765–74.CrossRefGoogle Scholar
  2. 2.
    Deschamps F, Harris KR, Moine L, et al. Pickering-emulsion for liver trans-arterial chemo-embolization with oxaliplatin. Cardiovasc Interv Radiol. 2018;41(5):781–8.CrossRefGoogle Scholar
  3. 3.
    Deschamps F, Moine L, Isoardo T, et al. Parameters for stable water-in-oil lipiodol emulsion for liver trans-arterial chemo-embolization. Cardiovasc Interv Radiol. 2017;40(12):1927–32.CrossRefGoogle Scholar
  4. 4.
    European Association For The Study Of The L, European Organisation For R, Treatment Of C. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012;56(4):908–43.CrossRefGoogle Scholar
  5. 5.
    Gaba RC, Lokken RP, Hickey RM, et al. Quality improvement guidelines for transarterial chemoembolization and embolization of hepatic malignancy. J Vasc Interv Radiol. 2017;28(9):1210–23.CrossRefGoogle Scholar
  6. 6.
    Golfieri R, Giampalma E, Renzulli M, et al. Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma. Br J Cancer. 2014;111(2):255–64.CrossRefGoogle Scholar
  7. 7.
    Guiu B, Chevallier P, Assenat E, et al. Idarubicin-loaded beads for chemoembolization of hepatocellular carcinoma: the IDASPHERE II single-arm phase II trial. Radiology. 2019;291(3):801–8.CrossRefGoogle Scholar
  8. 8.
    He MK, Zou RH, Wei W, et al. Comparison of stable and unstable ethiodized oil emulsions for transarterial chemoembolization of hepatocellular carcinoma: results of a single-center double-blind prospective randomized controlled trial. J Vasc Interv Radiol. 2018;29(8):1068–77.CrossRefGoogle Scholar
  9. 9.
    Lammer J, Malagari K, Vogl T, et al. Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Interv Radiol. 2010;33(1):41–52.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2019

Authors and Affiliations

  1. 1.Interventional Radiology DepartmentHôpital Européen Georges Pompidou, Assistance Publique - Hôpitaux de ParisParisFrance
  2. 2.Faculté de MédecineUniversité Paris Descartes, Sorbonne Paris CitéParisFrance
  3. 3.INSERM U970ParisFrance
  4. 4.Interventional Radiology DepartmentSt-Eloi University Hospital –Montpellier School of MedicineMontpellierFrance

Personalised recommendations